Loading…
Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies
A rapid, sensitive and simple liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti‐thrombotic agent S002‐333 [2‐(4‐methoxy‐benzenesulfonyl)‐2,3,4,9‐tetrahydro‐1H‐β‐carboxylic acid amide] in rabbit plasma w...
Saved in:
Published in: | Biomedical chromatography 2010-11, Vol.24 (11), p.1234-1239 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593 |
---|---|
cites | cdi_FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593 |
container_end_page | 1239 |
container_issue | 11 |
container_start_page | 1234 |
container_title | Biomedical chromatography |
container_volume | 24 |
creator | Bhatta, R. S. Kumar, D. Chhonker, Y. S. Saxena, A. K. Jain, G. K. |
description | A rapid, sensitive and simple liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti‐thrombotic agent S002‐333 [2‐(4‐methoxy‐benzenesulfonyl)‐2,3,4,9‐tetrahydro‐1H‐β‐carboxylic acid amide] in rabbit plasma was developed and validated. The extraction from plasma was carried out by simple protein precipitation extraction method. The chromatographic separation was performed on an Ultramex Cyno, (150 × 4.6 mm, 5 µm) with a guard column, using acetonitrile–water (75:25,v/v) with flow rate of 0.6 mL/min as the mobile phase. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z transitions 386.4/215.4 for S002‐333 and m/z 393.4/171for the internal standard dexamethasone, using positive ion mode. The MS/MS response was linear over the concentration range from 1.56 to 200 ng/mL, with a lower limit of detection of 0.78 ng/mL. The accuracy and precision of the method were within the acceptable limit of ±20% at the lower limit of quantitation and ±15% at other concentrations and showed no significant matrix effect. The validated method can be used in most or all stages of the screening and optimizing process for future method validation of pharmacokinetic studies Copyright © 2010 John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/bmc.1433 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_759134789</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1399903096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi0EoktB4gmQb3BJa8exEx_pqhSkXTgE1KNlOxPW1IlD7C3sY_DGOO1STiBZsuT5_M1ofoReUnJGCSnPzWDPaMXYI7SiRMqCNIQ-RitSClmwppYn6FmM3wghUpT1U3RSEsmrkooV-nXhgh61PyRntccDpF3ocAe34MM0wJiwHjt8q73rdHJhxKHHY8jV_J5c2s1hMCH_xfrrArd5moIxhs0Bb9bFtj3ftncGlyLW0-RzlztNCnja6XnQNty4ERZDTPvOQXyOnvTaR3hxvE_Rl3eXn9fvi82nqw_rt5vCMklZoY0RzHJek6Y2wJuyElbITgrDmopqbmQtLavyJioQhAkqm570laD5AHDJTtHre-80h-97iEkNLlrwXo8Q9lHVPLep6mYh3_yXpExKSVhe7l_UziHGGXo1zW7Q80FRopaoVI5KLVFl9NXRujcDdA_gn2wyUNwDP5yHwz9F6mK7PgqPvIsJfj7wer5RomY1V9cfrxSnTXu9KaVq2W9aBasV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1399903096</pqid></control><display><type>article</type><title>Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</title><source>Wiley</source><creator>Bhatta, R. S. ; Kumar, D. ; Chhonker, Y. S. ; Saxena, A. K. ; Jain, G. K.</creator><creatorcontrib>Bhatta, R. S. ; Kumar, D. ; Chhonker, Y. S. ; Saxena, A. K. ; Jain, G. K.</creatorcontrib><description>A rapid, sensitive and simple liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti‐thrombotic agent S002‐333 [2‐(4‐methoxy‐benzenesulfonyl)‐2,3,4,9‐tetrahydro‐1H‐β‐carboxylic acid amide] in rabbit plasma was developed and validated. The extraction from plasma was carried out by simple protein precipitation extraction method. The chromatographic separation was performed on an Ultramex Cyno, (150 × 4.6 mm, 5 µm) with a guard column, using acetonitrile–water (75:25,v/v) with flow rate of 0.6 mL/min as the mobile phase. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z transitions 386.4/215.4 for S002‐333 and m/z 393.4/171for the internal standard dexamethasone, using positive ion mode. The MS/MS response was linear over the concentration range from 1.56 to 200 ng/mL, with a lower limit of detection of 0.78 ng/mL. The accuracy and precision of the method were within the acceptable limit of ±20% at the lower limit of quantitation and ±15% at other concentrations and showed no significant matrix effect. The validated method can be used in most or all stages of the screening and optimizing process for future method validation of pharmacokinetic studies Copyright © 2010 John Wiley & Sons, Ltd.</description><identifier>ISSN: 0269-3879</identifier><identifier>EISSN: 1099-0801</identifier><identifier>DOI: 10.1002/bmc.1433</identifier><identifier>PMID: 20954216</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Animals ; antithrombitic ; Carbolines - blood ; Carbolines - pharmacokinetics ; Chromatography, High Pressure Liquid - methods ; Fibrinolytic Agents - blood ; Fibrinolytic Agents - pharmacokinetics ; LC-MS/MS ; Male ; pharmacokinetics ; preclinical ; Rabbits ; Sulfonamides - blood ; Sulfonamides - pharmacokinetics ; Tandem Mass Spectrometry - methods</subject><ispartof>Biomedical chromatography, 2010-11, Vol.24 (11), p.1234-1239</ispartof><rights>Copyright © 2010 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593</citedby><cites>FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20954216$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhatta, R. S.</creatorcontrib><creatorcontrib>Kumar, D.</creatorcontrib><creatorcontrib>Chhonker, Y. S.</creatorcontrib><creatorcontrib>Saxena, A. K.</creatorcontrib><creatorcontrib>Jain, G. K.</creatorcontrib><title>Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</title><title>Biomedical chromatography</title><addtitle>Biomed. Chromatogr</addtitle><description>A rapid, sensitive and simple liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti‐thrombotic agent S002‐333 [2‐(4‐methoxy‐benzenesulfonyl)‐2,3,4,9‐tetrahydro‐1H‐β‐carboxylic acid amide] in rabbit plasma was developed and validated. The extraction from plasma was carried out by simple protein precipitation extraction method. The chromatographic separation was performed on an Ultramex Cyno, (150 × 4.6 mm, 5 µm) with a guard column, using acetonitrile–water (75:25,v/v) with flow rate of 0.6 mL/min as the mobile phase. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z transitions 386.4/215.4 for S002‐333 and m/z 393.4/171for the internal standard dexamethasone, using positive ion mode. The MS/MS response was linear over the concentration range from 1.56 to 200 ng/mL, with a lower limit of detection of 0.78 ng/mL. The accuracy and precision of the method were within the acceptable limit of ±20% at the lower limit of quantitation and ±15% at other concentrations and showed no significant matrix effect. The validated method can be used in most or all stages of the screening and optimizing process for future method validation of pharmacokinetic studies Copyright © 2010 John Wiley & Sons, Ltd.</description><subject>Animals</subject><subject>antithrombitic</subject><subject>Carbolines - blood</subject><subject>Carbolines - pharmacokinetics</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Fibrinolytic Agents - blood</subject><subject>Fibrinolytic Agents - pharmacokinetics</subject><subject>LC-MS/MS</subject><subject>Male</subject><subject>pharmacokinetics</subject><subject>preclinical</subject><subject>Rabbits</subject><subject>Sulfonamides - blood</subject><subject>Sulfonamides - pharmacokinetics</subject><subject>Tandem Mass Spectrometry - methods</subject><issn>0269-3879</issn><issn>1099-0801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAQhi0EoktB4gmQb3BJa8exEx_pqhSkXTgE1KNlOxPW1IlD7C3sY_DGOO1STiBZsuT5_M1ofoReUnJGCSnPzWDPaMXYI7SiRMqCNIQ-RitSClmwppYn6FmM3wghUpT1U3RSEsmrkooV-nXhgh61PyRntccDpF3ocAe34MM0wJiwHjt8q73rdHJhxKHHY8jV_J5c2s1hMCH_xfrrArd5moIxhs0Bb9bFtj3ftncGlyLW0-RzlztNCnja6XnQNty4ERZDTPvOQXyOnvTaR3hxvE_Rl3eXn9fvi82nqw_rt5vCMklZoY0RzHJek6Y2wJuyElbITgrDmopqbmQtLavyJioQhAkqm570laD5AHDJTtHre-80h-97iEkNLlrwXo8Q9lHVPLep6mYh3_yXpExKSVhe7l_UziHGGXo1zW7Q80FRopaoVI5KLVFl9NXRujcDdA_gn2wyUNwDP5yHwz9F6mK7PgqPvIsJfj7wer5RomY1V9cfrxSnTXu9KaVq2W9aBasV</recordid><startdate>201011</startdate><enddate>201011</enddate><creator>Bhatta, R. S.</creator><creator>Kumar, D.</creator><creator>Chhonker, Y. S.</creator><creator>Saxena, A. K.</creator><creator>Jain, G. K.</creator><general>John Wiley & Sons, Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201011</creationdate><title>Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</title><author>Bhatta, R. S. ; Kumar, D. ; Chhonker, Y. S. ; Saxena, A. K. ; Jain, G. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>antithrombitic</topic><topic>Carbolines - blood</topic><topic>Carbolines - pharmacokinetics</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Fibrinolytic Agents - blood</topic><topic>Fibrinolytic Agents - pharmacokinetics</topic><topic>LC-MS/MS</topic><topic>Male</topic><topic>pharmacokinetics</topic><topic>preclinical</topic><topic>Rabbits</topic><topic>Sulfonamides - blood</topic><topic>Sulfonamides - pharmacokinetics</topic><topic>Tandem Mass Spectrometry - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhatta, R. S.</creatorcontrib><creatorcontrib>Kumar, D.</creatorcontrib><creatorcontrib>Chhonker, Y. S.</creatorcontrib><creatorcontrib>Saxena, A. K.</creatorcontrib><creatorcontrib>Jain, G. K.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedical chromatography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhatta, R. S.</au><au>Kumar, D.</au><au>Chhonker, Y. S.</au><au>Saxena, A. K.</au><au>Jain, G. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies</atitle><jtitle>Biomedical chromatography</jtitle><addtitle>Biomed. Chromatogr</addtitle><date>2010-11</date><risdate>2010</risdate><volume>24</volume><issue>11</issue><spage>1234</spage><epage>1239</epage><pages>1234-1239</pages><issn>0269-3879</issn><eissn>1099-0801</eissn><abstract>A rapid, sensitive and simple liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method using an electrospray ionization (ECI) source for the quantification of novel anti‐thrombotic agent S002‐333 [2‐(4‐methoxy‐benzenesulfonyl)‐2,3,4,9‐tetrahydro‐1H‐β‐carboxylic acid amide] in rabbit plasma was developed and validated. The extraction from plasma was carried out by simple protein precipitation extraction method. The chromatographic separation was performed on an Ultramex Cyno, (150 × 4.6 mm, 5 µm) with a guard column, using acetonitrile–water (75:25,v/v) with flow rate of 0.6 mL/min as the mobile phase. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode to monitor the m/z transitions 386.4/215.4 for S002‐333 and m/z 393.4/171for the internal standard dexamethasone, using positive ion mode. The MS/MS response was linear over the concentration range from 1.56 to 200 ng/mL, with a lower limit of detection of 0.78 ng/mL. The accuracy and precision of the method were within the acceptable limit of ±20% at the lower limit of quantitation and ±15% at other concentrations and showed no significant matrix effect. The validated method can be used in most or all stages of the screening and optimizing process for future method validation of pharmacokinetic studies Copyright © 2010 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>20954216</pmid><doi>10.1002/bmc.1433</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0269-3879 |
ispartof | Biomedical chromatography, 2010-11, Vol.24 (11), p.1234-1239 |
issn | 0269-3879 1099-0801 |
language | eng |
recordid | cdi_proquest_miscellaneous_759134789 |
source | Wiley |
subjects | Animals antithrombitic Carbolines - blood Carbolines - pharmacokinetics Chromatography, High Pressure Liquid - methods Fibrinolytic Agents - blood Fibrinolytic Agents - pharmacokinetics LC-MS/MS Male pharmacokinetics preclinical Rabbits Sulfonamides - blood Sulfonamides - pharmacokinetics Tandem Mass Spectrometry - methods |
title | Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A16%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bioanalytical%20method%20development%20and%20validation%20of%20novel%20antithrombotic%20agent%20S002-333%20by%20LC-MS/MS%20and%20its%20application%20to%20pharmacokinetic%20studies&rft.jtitle=Biomedical%20chromatography&rft.au=Bhatta,%20R.%20S.&rft.date=2010-11&rft.volume=24&rft.issue=11&rft.spage=1234&rft.epage=1239&rft.pages=1234-1239&rft.issn=0269-3879&rft.eissn=1099-0801&rft_id=info:doi/10.1002/bmc.1433&rft_dat=%3Cproquest_cross%3E1399903096%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3913-abb63c557087be58246c69d96b3841a5b979c340804e6036198f0f461461ee593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1399903096&rft_id=info:pmid/20954216&rfr_iscdi=true |